EUROFINS BIOSKIN
LIVE

Serial Number

97205945

Owner

EUROFINS SCIENTIFIC (IRELAND) LIMITED

Attorney

Joseph Sofer, Esq.

First Use Date

Nov 1, 2021

Filing Date

Jan 6, 2022

Add to watchlist:

No watchlists yet
View on USPTO

EUROFINS BIOSKIN Trademark

Serial Number: 97205945 • Registration: 7295268

EUROFINS BIOSKIN is a trademark filed by EUROFINS SCIENTIFIC (IRELAND) LIMITED on January 6, 2022. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

EUROFINS SCIENTIFIC (IRELAND) LIMITED (44 trademarks)

Entity Type: 99

Trademark Details

Filing Date

January 6, 2022

Registration Date

January 30, 2024

First Use Anywhere

November 1, 2021

First Use in Commerce

November 1, 2021

Published for Opposition

May 9, 2023

Goods & Services

Medical services, namely, blood testing, saliva, urine, tissue, hair and body fluid testing services; serological and urinary testing services for medical, epidemiological purposes; medical testing services relating to the diagnosis and treatment of disease in the field of epidemiology and genetics; medical clinic services; medical consultation services; hygienic and beauty care for human beings; collection, sampling and preservation of human blood, saliva, urine, tissue, hair and body fluids; medical testing for diagnostic and epidemiological purposes, namely, for the diagnosis and treatment of disease; medical diagnostic testing in the field of anti-ageing medicine; medical information services, namely, carrying out medical biology test panels and interpretation of medical biology test results; allergy and immunology testing for medical purposes; medical testing services relating to the diagnosis and treatment of disease, namely, infectious disease testing

Scientific and industrial research in the physico-chemical, microbiology, molecular biology, chemistry, biochemistry, epidemiological, microbiological, molecular biological, pharmaceutical, dermatological, genetic, biotechnological, and immunological fields; carrying out physical, chemical, physical-chemical, biochemical, biological, epidemiological, microbiological, molecular biological or immunological analyses for scientific research purposes, and conducting scientific research in the nature of clinical studies in the pharmaceutical, medical device, cosmetic, personal care industries; scientific and industrial research in the pharmaceutical, medical device, cosmetic, personal care fields; development of methods, namely, development and establishment of testing specifications and procedures in the field of physical, chemical, physical-chemical, biochemical, biological, epidemiological, microbiological, molecular biological, immunological and biomolecular sciences; scientific research in the nature of preparing scientific, medical or industrial expert reports for scientists and engineers; technical research, namely, conducting technical project studies in the physico-chemical, microbiology, molecular biology, chemistry, biochemistry, epidemiological, microbiological, molecular biological, pharmaceutical, dermatological, genetic, biotechnological, and immunological fields; professional consultancy in the field of scientific and medical research; scientific and technological services, namely, scientific research, analysis, inspection, audit, consulting, design, engineering, development and laboratory testing services for others in the physico-chemical, microbiology, molecular biology, chemistry, biochemistry, epidemiological, microbiological, molecular biological, pharmaceutical, dermatological, genetic, biotechnological, and immunological fields; scientific and technological services, namely, product development, commercialisation, life cycle management, and improvement of products manufactured by pharmaceutical, medical device, and other science-oriented industries; consulting and advisory services related to analytical techniques for scientific research and product development processes; consulting and advisory services related to product development, life cycle management, and improvement of products manufactured by pharmaceutical, medical device and other science-oriented industries; consumer product safety testing; product safety testing; testing of new products; consultancy relating to consumer product safety testing; design and testing of new products for others; scientific and technical research for others for pharmaceuticals, biotech products and chemicals; development and research in the fields of pharmaceuticals, biotech products; medical and scientific research in the nature of conducting clinical trials for others relating to medical devices and pharmaceuticals in the field of dermatology; medical and scientific research in the nature of conducting clinical trials for others in the fields of pharmaceuticals, medical devices, products, cosmetics and personal care products; medical and scientific research services for ensuring safety and efficiency of pharmaceutical drugs and medical devices; pharmaceutical, biopharmaceutical and clinical product research and development for others

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 30, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 30, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 28, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 27, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 9, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 9, 2023 AITU
USE AMENDMENT FILED
Nov 30, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 30, 2023 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 4, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 9, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 9, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 19, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 4, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 28, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 27, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 27, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 19, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 19, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 19, 2022 CNRT
ASSIGNED TO EXAMINER
Oct 13, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 14, 2022 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2022 NWOS
NEW APPLICATION ENTERED
Jan 10, 2022 NWAP